IOL Chemicals and Pharmaceuticals Limited has issued a regulatory disclosure to the National Stock Exchange of India Ltd. and BSE Limited regarding an upcoming board meeting. The notice is submitted under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board of Directors meeting is scheduled for Monday, 10th August 2026. The primary agenda item is to consider and approve the Unaudited Financial Results of the Company for the quarter ended 30th June 2026 (Q1 FY27).
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's "Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons," the Trading Window has been closed since 1st July 2026. The window will remain closed until 48 hours after the unaudited financial results for the quarter ended 30th June 2026 are made public. Accordingly, the trading window is scheduled to reopen on 13th August 2026.
The disclosure was signed digitally by Abhay Raj Singh, Sr. Vice President & Company Secretary, on 3rd August 2026 at 16:29:09 IST.